Analysis | Metabolite Name | Measured Value | Units | Sample type | Gender |
---|---|---|---|---|---|
Reversed Phase NEGATIVE (Named metabolites) | glutamine | 519 | Peak area normalized | Sample | female |
Reversed Phase NEGATIVE (Named metabolites) | glutamine | 1011 | Peak area normalized | Sample | female |
Reversed Phase NEGATIVE (Named metabolites) | glutamine | 1523 | Peak area normalized | Sample | female |
Reversed Phase NEGATIVE (Named metabolites) | glutamine | 42584 | Peak area normalized | chear plasma | - |
Reversed Phase NEGATIVE (Named metabolites) | glutamine | 43321 | Peak area normalized | chear plasma | - |
Reversed Phase NEGATIVE (Named metabolites) | glutamine | 46318 | Peak area normalized | chear plasma | - |
Reversed Phase NEGATIVE (Named metabolites) | glutamine | 47254 | Peak area normalized | chear plasma | - |
Reversed Phase NEGATIVE (Named metabolites) | glutamine | 47400 | Peak area normalized | chear plasma | - |
Reversed Phase NEGATIVE (Named metabolites) | glutamine | 47419 | Peak area normalized | chear plasma | - |
Reversed Phase NEGATIVE (Named metabolites) | glutamine | 47806 | Peak area normalized | chear plasma | - |
Reversed Phase NEGATIVE (Named metabolites) | glutamine | 48551 | Peak area normalized | chear plasma | - |
Reversed Phase NEGATIVE (Named metabolites) | glutamine | 57372 | Peak area normalized | chear plasma | - |
Reversed Phase NEGATIVE (Named metabolites) | glutamine | 58127 | Peak area normalized | chear plasma | - |
Reversed Phase NEGATIVE (Named metabolites) | glutamine | 61663 | Peak area normalized | chear plasma | - |
Reversed Phase NEGATIVE (Named metabolites) | glutamine | 64305 | Peak area normalized | chear plasma | - |
Reversed Phase NEGATIVE (Named metabolites) | glutamine | 81724 | Peak area normalized | red cross plasma | - |
Reversed Phase NEGATIVE (Named metabolites) | glutamine | 84651 | Peak area normalized | red cross plasma | - |
Reversed Phase NEGATIVE (Named metabolites) | glutamine | 91029 | Peak area normalized | red cross plasma | - |
Reversed Phase NEGATIVE (Named metabolites) | glutamine | 91233 | Peak area normalized | red cross plasma | - |
Reversed Phase NEGATIVE (Named metabolites) | glutamine | 92201 | Peak area normalized | red cross plasma | - |
Reversed Phase NEGATIVE (Named metabolites) | glutamine | 93787 | Peak area normalized | red cross plasma | - |
Reversed Phase NEGATIVE (Named metabolites) | glutamine | 96302 | Peak area normalized | red cross plasma | - |
Reversed Phase NEGATIVE (Named metabolites) | glutamine | 96672 | Peak area normalized | red cross plasma | - |
Reversed Phase NEGATIVE (Named metabolites) | glutamine | 104108 | Peak area normalized | red cross plasma | - |
Reversed Phase NEGATIVE (Named metabolites) | glutamine | 104895 | Peak area normalized | Sample | female |
Reversed Phase NEGATIVE (Named metabolites) | glutamine | 105100 | Peak area normalized | red cross plasma | - |
Reversed Phase NEGATIVE (Named metabolites) | glutamine | 106584 | Peak area normalized | red cross plasma | - |
Reversed Phase NEGATIVE (Named metabolites) | glutamine | 110750 | Peak area normalized | red cross plasma | - |
Reversed Phase NEGATIVE (Named metabolites) | glutamine | 118754 | Peak area normalized | Sample | female |
Reversed Phase NEGATIVE (Named metabolites) | glutamine | 127360 | Peak area normalized | Sample | male |
Reversed Phase NEGATIVE (Named metabolites) | glutamine | 137340 | Peak area normalized | Sample | male |
Reversed Phase NEGATIVE (Named metabolites) | glutamine | 139038 | Peak area normalized | Sample | male |
Reversed Phase NEGATIVE (Named metabolites) | glutamine | 143827 | Peak area normalized | Sample | female |
Reversed Phase NEGATIVE (Named metabolites) | glutamine | 143841 | Peak area normalized | Sample | female |
Reversed Phase NEGATIVE (Named metabolites) | glutamine | 150928 | Peak area normalized | Sample | male |
Reversed Phase NEGATIVE (Named metabolites) | glutamine | 152469 | Peak area normalized | Sample | male |
Reversed Phase NEGATIVE (Named metabolites) | glutamine | 153479 | Peak area normalized | Sample | female |
Reversed Phase NEGATIVE (Named metabolites) | glutamine | 153582 | Peak area normalized | Sample | male |
Reversed Phase NEGATIVE (Named metabolites) | glutamine | 154312 | Peak area normalized | Sample | male |
Reversed Phase NEGATIVE (Named metabolites) | glutamine | 156131 | Peak area normalized | Sample | male |
Reversed Phase NEGATIVE (Named metabolites) | glutamine | 156211 | Peak area normalized | Sample | male |
Reversed Phase NEGATIVE (Named metabolites) | glutamine | 156476 | Peak area normalized | Sample | male |
Reversed Phase NEGATIVE (Named metabolites) | glutamine | 156556 | Peak area normalized | Sample | male |
Reversed Phase NEGATIVE (Named metabolites) | glutamine | 156721 | Peak area normalized | Sample | male |
Reversed Phase NEGATIVE (Named metabolites) | glutamine | 156944 | Peak area normalized | Sample | female |
Reversed Phase NEGATIVE (Named metabolites) | glutamine | 157673 | Peak area normalized | Sample | male |
Reversed Phase NEGATIVE (Named metabolites) | glutamine | 158185 | Peak area normalized | Sample | male |
Reversed Phase NEGATIVE (Named metabolites) | glutamine | 159405 | Peak area normalized | Sample | female |
Reversed Phase NEGATIVE (Named metabolites) | glutamine | 160401 | Peak area normalized | Sample | male |
Reversed Phase NEGATIVE (Named metabolites) | glutamine | 161797 | Peak area normalized | Sample | female |
Reversed Phase NEGATIVE (Named metabolites) | glutamine | 163054 | Peak area normalized | Sample | male |
Reversed Phase NEGATIVE (Named metabolites) | glutamine | 163061 | Peak area normalized | Sample | male |
Reversed Phase NEGATIVE (Named metabolites) | glutamine | 163262 | Peak area normalized | Sample | female |
Reversed Phase NEGATIVE (Named metabolites) | glutamine | 163461 | Peak area normalized | Sample | male |
Reversed Phase NEGATIVE (Named metabolites) | glutamine | 164379 | Peak area normalized | Sample | female |
Reversed Phase NEGATIVE (Named metabolites) | glutamine | 164609 | Peak area normalized | Sample | male |
Reversed Phase NEGATIVE (Named metabolites) | glutamine | 165287 | Peak area normalized | Sample | male |
Reversed Phase NEGATIVE (Named metabolites) | glutamine | 167195 | Peak area normalized | Sample | female |
Reversed Phase NEGATIVE (Named metabolites) | glutamine | 168664 | Peak area normalized | Sample | female |
Reversed Phase NEGATIVE (Named metabolites) | glutamine | 169481 | Peak area normalized | Sample | male |
Reversed Phase NEGATIVE (Named metabolites) | glutamine | 170610 | Peak area normalized | Sample | female |
Reversed Phase NEGATIVE (Named metabolites) | glutamine | 170625 | Peak area normalized | Sample | female |
Reversed Phase NEGATIVE (Named metabolites) | glutamine | 170712 | Peak area normalized | Sample | female |
Reversed Phase NEGATIVE (Named metabolites) | glutamine | 171130 | Peak area normalized | Sample | male |
Reversed Phase NEGATIVE (Named metabolites) | glutamine | 171348 | Peak area normalized | Sample | female |
Reversed Phase NEGATIVE (Named metabolites) | glutamine | 172005 | Peak area normalized | Sample | male |
Reversed Phase NEGATIVE (Named metabolites) | glutamine | 172506 | Peak area normalized | Sample | male |
Reversed Phase NEGATIVE (Named metabolites) | glutamine | 172839 | Peak area normalized | Sample | male |
Reversed Phase NEGATIVE (Named metabolites) | glutamine | 172984 | Peak area normalized | Sample | male |
Reversed Phase NEGATIVE (Named metabolites) | glutamine | 173047 | Peak area normalized | Sample | male |
Reversed Phase NEGATIVE (Named metabolites) | glutamine | 173769 | Peak area normalized | Sample | female |
Reversed Phase NEGATIVE (Named metabolites) | glutamine | 173803 | Peak area normalized | Sample | female |
Reversed Phase NEGATIVE (Named metabolites) | glutamine | 173873 | Peak area normalized | Sample | male |
Reversed Phase NEGATIVE (Named metabolites) | glutamine | 175967 | Peak area normalized | Sample | male |
Reversed Phase NEGATIVE (Named metabolites) | glutamine | 176631 | Peak area normalized | Sample | female |
Reversed Phase NEGATIVE (Named metabolites) | glutamine | 177046 | Peak area normalized | Sample | male |
Reversed Phase NEGATIVE (Named metabolites) | glutamine | 177632 | Peak area normalized | Sample | female |
Reversed Phase NEGATIVE (Named metabolites) | glutamine | 177960 | Peak area normalized | Sample | male |
Reversed Phase NEGATIVE (Named metabolites) | glutamine | 178441 | Peak area normalized | Sample | female |
Reversed Phase NEGATIVE (Named metabolites) | glutamine | 178505 | Peak area normalized | Sample | female |
Reversed Phase NEGATIVE (Named metabolites) | glutamine | 179056 | Peak area normalized | Sample | male |
Reversed Phase NEGATIVE (Named metabolites) | glutamine | 179657 | Peak area normalized | Sample | female |
Reversed Phase NEGATIVE (Named metabolites) | glutamine | 180355 | Peak area normalized | Sample | male |
Reversed Phase NEGATIVE (Named metabolites) | glutamine | 181144 | Peak area normalized | Sample | male |
Reversed Phase NEGATIVE (Named metabolites) | glutamine | 181781 | Peak area normalized | Sample | male |
Reversed Phase NEGATIVE (Named metabolites) | glutamine | 181804 | Peak area normalized | Sample | male |
Reversed Phase NEGATIVE (Named metabolites) | glutamine | 182678 | Peak area normalized | Sample | male |
Reversed Phase NEGATIVE (Named metabolites) | glutamine | 182690 | Peak area normalized | Sample | male |
Reversed Phase NEGATIVE (Named metabolites) | glutamine | 183152 | Peak area normalized | Sample | female |
Reversed Phase NEGATIVE (Named metabolites) | glutamine | 183204 | Peak area normalized | Sample | male |
Reversed Phase NEGATIVE (Named metabolites) | glutamine | 183270 | Peak area normalized | Sample | male |
Reversed Phase NEGATIVE (Named metabolites) | glutamine | 184205 | Peak area normalized | Sample | female |
Reversed Phase NEGATIVE (Named metabolites) | glutamine | 184649 | Peak area normalized | Sample | male |
Reversed Phase NEGATIVE (Named metabolites) | glutamine | 184844 | Peak area normalized | Sample | male |
Reversed Phase NEGATIVE (Named metabolites) | glutamine | 184949 | Peak area normalized | Sample | male |
Reversed Phase NEGATIVE (Named metabolites) | glutamine | 185288 | Peak area normalized | Sample | male |
Reversed Phase NEGATIVE (Named metabolites) | glutamine | 186749 | Peak area normalized | Sample | male |
Reversed Phase NEGATIVE (Named metabolites) | glutamine | 186989 | Peak area normalized | Sample | female |
Reversed Phase NEGATIVE (Named metabolites) | glutamine | 187078 | Peak area normalized | Sample | male |
Reversed Phase NEGATIVE (Named metabolites) | glutamine | 187598 | Peak area normalized | Sample | female |
Reversed Phase NEGATIVE (Named metabolites) | glutamine | 187748 | Peak area normalized | Sample | male |
Reversed Phase NEGATIVE (Named metabolites) | glutamine | 188239 | Peak area normalized | Sample | female |
Reversed Phase NEGATIVE (Named metabolites) | glutamine | 189264 | Peak area normalized | Sample | female |
Reversed Phase NEGATIVE (Named metabolites) | glutamine | 189280 | Peak area normalized | Sample | female |
Reversed Phase NEGATIVE (Named metabolites) | glutamine | 189362 | Peak area normalized | Sample | male |
Reversed Phase NEGATIVE (Named metabolites) | glutamine | 189443 | Peak area normalized | Sample | female |
Reversed Phase NEGATIVE (Named metabolites) | glutamine | 189460 | Peak area normalized | Sample | male |
Reversed Phase NEGATIVE (Named metabolites) | glutamine | 189588 | Peak area normalized | Sample | female |
Reversed Phase NEGATIVE (Named metabolites) | glutamine | 190537 | Peak area normalized | Sample | male |
Reversed Phase NEGATIVE (Named metabolites) | glutamine | 190712 | Peak area normalized | Sample | female |
Reversed Phase NEGATIVE (Named metabolites) | glutamine | 190915 | Peak area normalized | Sample | female |
Reversed Phase NEGATIVE (Named metabolites) | glutamine | 191274 | Peak area normalized | Sample | female |
Reversed Phase NEGATIVE (Named metabolites) | glutamine | 191779 | Peak area normalized | Sample | female |
Reversed Phase NEGATIVE (Named metabolites) | glutamine | 191820 | Peak area normalized | Sample | male |
Reversed Phase NEGATIVE (Named metabolites) | glutamine | 192039 | Peak area normalized | Sample | male |
Reversed Phase NEGATIVE (Named metabolites) | glutamine | 192263 | Peak area normalized | Sample | female |
Reversed Phase NEGATIVE (Named metabolites) | glutamine | 192316 | Peak area normalized | Sample | female |
Reversed Phase NEGATIVE (Named metabolites) | glutamine | 192876 | Peak area normalized | Sample | male |
Reversed Phase NEGATIVE (Named metabolites) | glutamine | 193265 | Peak area normalized | Sample | male |
Reversed Phase NEGATIVE (Named metabolites) | glutamine | 193456 | Peak area normalized | Sample | male |
Reversed Phase NEGATIVE (Named metabolites) | glutamine | 193715 | Peak area normalized | Sample | female |
Reversed Phase NEGATIVE (Named metabolites) | glutamine | 193802 | Peak area normalized | Sample | male |
Reversed Phase NEGATIVE (Named metabolites) | glutamine | 194239 | Peak area normalized | Sample | male |
Reversed Phase NEGATIVE (Named metabolites) | glutamine | 194848 | Peak area normalized | Sample | female |
Reversed Phase NEGATIVE (Named metabolites) | glutamine | 195044 | Peak area normalized | Sample | male |
Reversed Phase NEGATIVE (Named metabolites) | glutamine | 195121 | Peak area normalized | Sample | male |
Reversed Phase NEGATIVE (Named metabolites) | glutamine | 195193 | Peak area normalized | Sample | male |
Reversed Phase NEGATIVE (Named metabolites) | glutamine | 195221 | Peak area normalized | Sample | male |
Reversed Phase NEGATIVE (Named metabolites) | glutamine | 195273 | Peak area normalized | Sample | female |
Reversed Phase NEGATIVE (Named metabolites) | glutamine | 195352 | Peak area normalized | Sample | female |
Reversed Phase NEGATIVE (Named metabolites) | glutamine | 196321 | Peak area normalized | Sample | male |
Reversed Phase NEGATIVE (Named metabolites) | glutamine | 196495 | Peak area normalized | Sample | male |
Reversed Phase NEGATIVE (Named metabolites) | glutamine | 197257 | Peak area normalized | Sample | female |
Reversed Phase NEGATIVE (Named metabolites) | glutamine | 197337 | Peak area normalized | Sample | male |
Reversed Phase NEGATIVE (Named metabolites) | glutamine | 197472 | Peak area normalized | Sample | female |
Reversed Phase NEGATIVE (Named metabolites) | glutamine | 198511 | Peak area normalized | Sample | male |
Reversed Phase NEGATIVE (Named metabolites) | glutamine | 198784 | Peak area normalized | Sample | male |
Reversed Phase NEGATIVE (Named metabolites) | glutamine | 198908 | Peak area normalized | Sample | male |
Reversed Phase NEGATIVE (Named metabolites) | glutamine | 199251 | Peak area normalized | Sample | male |
Reversed Phase NEGATIVE (Named metabolites) | glutamine | 199521 | Peak area normalized | Sample | male |
Reversed Phase NEGATIVE (Named metabolites) | glutamine | 199586 | Peak area normalized | Sample | female |
Reversed Phase NEGATIVE (Named metabolites) | glutamine | 200863 | Peak area normalized | Sample | female |
Reversed Phase NEGATIVE (Named metabolites) | glutamine | 201117 | Peak area normalized | Sample | female |
Reversed Phase NEGATIVE (Named metabolites) | glutamine | 201329 | Peak area normalized | Sample | male |
Reversed Phase NEGATIVE (Named metabolites) | glutamine | 201354 | Peak area normalized | Sample | female |
Reversed Phase NEGATIVE (Named metabolites) | glutamine | 201534 | Peak area normalized | Sample | female |
Reversed Phase NEGATIVE (Named metabolites) | glutamine | 201637 | Peak area normalized | Sample | female |
Reversed Phase NEGATIVE (Named metabolites) | glutamine | 201769 | Peak area normalized | Sample | female |
Reversed Phase NEGATIVE (Named metabolites) | glutamine | 202171 | Peak area normalized | Sample | female |
Reversed Phase NEGATIVE (Named metabolites) | glutamine | 202251 | Peak area normalized | Sample | female |
Reversed Phase NEGATIVE (Named metabolites) | glutamine | 202427 | Peak area normalized | Sample | male |
Reversed Phase NEGATIVE (Named metabolites) | glutamine | 202977 | Peak area normalized | Sample | female |
Reversed Phase NEGATIVE (Named metabolites) | glutamine | 203442 | Peak area normalized | Sample | male |
Reversed Phase NEGATIVE (Named metabolites) | glutamine | 203866 | Peak area normalized | Sample | female |
Reversed Phase NEGATIVE (Named metabolites) | glutamine | 204021 | Peak area normalized | Sample | male |
Reversed Phase NEGATIVE (Named metabolites) | glutamine | 204342 | Peak area normalized | Sample | female |
Reversed Phase NEGATIVE (Named metabolites) | glutamine | 204564 | Peak area normalized | Sample | female |
Reversed Phase NEGATIVE (Named metabolites) | glutamine | 205101 | Peak area normalized | Sample | female |
Reversed Phase NEGATIVE (Named metabolites) | glutamine | 205179 | Peak area normalized | Sample | male |
Reversed Phase NEGATIVE (Named metabolites) | glutamine | 205361 | Peak area normalized | Sample | female |
Reversed Phase NEGATIVE (Named metabolites) | glutamine | 205505 | Peak area normalized | Sample | male |
Reversed Phase NEGATIVE (Named metabolites) | glutamine | 206008 | Peak area normalized | Sample | female |
Reversed Phase NEGATIVE (Named metabolites) | glutamine | 208228 | Peak area normalized | Sample | female |
Reversed Phase NEGATIVE (Named metabolites) | glutamine | 209908 | Peak area normalized | Sample | female |
Reversed Phase NEGATIVE (Named metabolites) | glutamine | 210073 | Peak area normalized | master pool | - |
Reversed Phase NEGATIVE (Named metabolites) | glutamine | 210093 | Peak area normalized | Sample | female |
Reversed Phase NEGATIVE (Named metabolites) | glutamine | 211492 | Peak area normalized | Sample | male |
Reversed Phase NEGATIVE (Named metabolites) | glutamine | 211757 | Peak area normalized | Sample | female |
Reversed Phase NEGATIVE (Named metabolites) | glutamine | 212066 | Peak area normalized | Sample | female |
Reversed Phase NEGATIVE (Named metabolites) | glutamine | 212478 | Peak area normalized | batch pool | - |
Reversed Phase NEGATIVE (Named metabolites) | glutamine | 212522 | Peak area normalized | master pool | - |
Reversed Phase NEGATIVE (Named metabolites) | glutamine | 212822 | Peak area normalized | batch pool | - |
Reversed Phase NEGATIVE (Named metabolites) | glutamine | 213029 | Peak area normalized | batch pool | - |
Reversed Phase NEGATIVE (Named metabolites) | glutamine | 213559 | Peak area normalized | Sample | female |
Reversed Phase NEGATIVE (Named metabolites) | glutamine | 213582 | Peak area normalized | batch pool | - |
Reversed Phase NEGATIVE (Named metabolites) | glutamine | 213858 | Peak area normalized | master pool | - |
Reversed Phase NEGATIVE (Named metabolites) | glutamine | 213950 | Peak area normalized | batch pool | - |
Reversed Phase NEGATIVE (Named metabolites) | glutamine | 214140 | Peak area normalized | Sample | female |
Reversed Phase NEGATIVE (Named metabolites) | glutamine | 214513 | Peak area normalized | Sample | male |
Reversed Phase NEGATIVE (Named metabolites) | glutamine | 214587 | Peak area normalized | batch pool | - |
Reversed Phase NEGATIVE (Named metabolites) | glutamine | 214663 | Peak area normalized | Sample | female |
Reversed Phase NEGATIVE (Named metabolites) | glutamine | 214740 | Peak area normalized | batch pool | - |
Reversed Phase NEGATIVE (Named metabolites) | glutamine | 214813 | Peak area normalized | batch pool | - |
Reversed Phase NEGATIVE (Named metabolites) | glutamine | 214964 | Peak area normalized | Sample | female |
Reversed Phase NEGATIVE (Named metabolites) | glutamine | 215056 | Peak area normalized | batch pool | - |
Reversed Phase NEGATIVE (Named metabolites) | glutamine | 215142 | Peak area normalized | batch pool | - |
Reversed Phase NEGATIVE (Named metabolites) | glutamine | 215185 | Peak area normalized | master pool | - |
Reversed Phase NEGATIVE (Named metabolites) | glutamine | 215381 | Peak area normalized | batch pool | - |
Reversed Phase NEGATIVE (Named metabolites) | glutamine | 215416 | Peak area normalized | batch pool | - |
Reversed Phase NEGATIVE (Named metabolites) | glutamine | 215458 | Peak area normalized | master pool | - |
Reversed Phase NEGATIVE (Named metabolites) | glutamine | 215508 | Peak area normalized | master pool | - |
Reversed Phase NEGATIVE (Named metabolites) | glutamine | 215562 | Peak area normalized | Sample | female |
Reversed Phase NEGATIVE (Named metabolites) | glutamine | 215665 | Peak area normalized | batch pool | - |
Reversed Phase NEGATIVE (Named metabolites) | glutamine | 215822 | Peak area normalized | batch pool | - |
Reversed Phase NEGATIVE (Named metabolites) | glutamine | 215906 | Peak area normalized | batch pool | - |
Reversed Phase NEGATIVE (Named metabolites) | glutamine | 215910 | Peak area normalized | master pool | - |
Reversed Phase NEGATIVE (Named metabolites) | glutamine | 216011 | Peak area normalized | batch pool | - |
Reversed Phase NEGATIVE (Named metabolites) | glutamine | 216060 | Peak area normalized | batch pool | - |
Reversed Phase NEGATIVE (Named metabolites) | glutamine | 216109 | Peak area normalized | batch pool | - |
Reversed Phase NEGATIVE (Named metabolites) | glutamine | 216266 | Peak area normalized | batch pool | - |
Return to search page